Article · 4 May 2026
ArticlePublished 15 Nov 2024
Anticancer and Immunomodulatory Properties of Herbomineral Formulation Abhrak Bhasma on Breast Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Abhrak Bhasma (Shatputi) is a time tested classical Ayurvedic formulation, prepared from mica, as well as the juices of numerous other indigenous substances. In this work, we focus on the efficacy of Abharak Bhasma on anticancer activity and immunomodulatory effects using breast cancer Michigan Cancer Foundation-7 cell line and macrophage cell line Robert Abelson leukemia virus 264.7. The in vitro anti-cancer activities of the formulation were evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide assay. The percentage of cell death against Michigan Cancer Foundation-7 cell breast cancer cells increases with an increase in the concentration of Abhrak Bhasma. A high percentage of cell death (49.22±1.504 %) was observed at the concentration of 200 µg/ml of Abhrak Bhasma. The corresponding half-maximal inhibitory concentration value of Abhrak Bhasma was found to be 193.2±10.72 µg/ml. There was a dose-dependent decrease in the nitrite level in Robert Abelson leukemia virus 264.7 incubated with Abhrak Bhasma at the concentration ranges from 50 to 200 µg/ml. A significant reduction in nitrite level was found to be about 489.3±35.92 at 200 µg/ml. Lipopolysaccharide (1 µg/ml) treated was served as a control with a maximum nitrite level of about 1873±83.59 µg. The present study reveals that the percentage of cell viability in the macrophage cell line decreases with an increase in the concentration of Abhrak Bhasma. The least viability of the cell was observed at the concentration of 200 µg/ml showing 53.85±1.211 %. Our study highlights dual qualities of Abhrak Bhasma as a potential drug against breast cancer and as an immunomodulatory drug showing anti-inflammatory properties.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “K. S. Sree Lakshmi”
- BylineArticles whose byline prints “Geetha Nandagopalan”